Photo for representational purpose only. Reuters file
December 23
A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
The study, yet to be published in a peer-reviewed medical journal, showed antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from COVID-19.
After a three-dose course of the vaccine, neutralising levels against Omicron were similar to those against the virus’s Delta variant after two doses, the company added.
The Anglo-Swedish drugmaker said researchers at Oxford University who carried out the study were independent from those who worked on the vaccine, Vaxzevria, with AstraZeneca. Reuters
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Bibhav Kumar said ‘Neech aurat, tujhe sabak sikhayenge’, repeatedly slapped me, kicked me in the chest, pelvis while I had periods, alleges Swati Maliwal in FIR
The Rajya Sabha MP of the Aam Aadmi Party gives a graphic ac...
'Political hitman' back to old ways of saving himself: Swati Maliwal on video footage surfacing from Kejriwal's house
A video from Kejriwal’s house has surfaced
Bridges burnt—can Arvind Kejriwal and AAP recover from the Swati Maliwal controversy
While BJP makes it all about women’s ‘asmita’, unverified vi...
Interim bail eludes JMM leader Hemant Soren as Supreme Court defers hearing to Tuesday
A Bench of Justice Sanjiv Khanna and Justice Dipankar Datta ...
Ghatkopar hoarding collapse accused brought to Mumbai, to be produced in court today
Was apprehended from Udaipur in Rajasthan on Thursday
